BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia

DOI: 10.1080/2162402X.2016.1146843

Keywords: Acute myeloid leukemia, aminobisphosphonate, BTN3A, immunotherapy, monoclonal antibody, γδT cells

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text